IP Library Assignment 020933/0554
Patent Assignment
Reel/Frame 020933/0554

Assignment of Assignor's Interest

Recorded: 2008-05-12 Pages: 3
Assignors
MANG, ROSEMARIE
Executed: 2008-04-15
BERNER, HEINZ
Executed: 2008-04-25
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, WIEN, A-1112, AUSTRIA
Covered Property (1)
Organic Compounds
Patent: 8,343,972 →
Application: 11/997,637 →
Publication: US 2008/0306072
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Lien Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Release of Security Interest Nov 19, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037093/0308 →
Corrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement. Dec 2, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037190/0424 →
Intellectual Property Security Agreement Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest. Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →